Cargando...

Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study

BACKGROUND: Varenicline, bupropion and nicotine replacement therapy (NRT) are three effective pharmacotherapies for smoking cessation, but data about their safety in pregnancy are limited. We assessed the risk of adverse perinatal outcomes and major congenital anomalies associated with the use of th...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Med
Main Authors: Tran, Duong Thuy, Preen, David B., Einarsdottir, Kristjana, Kemp-Casey, Anna, Randall, Deborah, Jorm, Louisa R., Choi, Stephanie K. Y., Havard, Alys
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001233/
https://ncbi.nlm.nih.gov/pubmed/32019533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-019-1472-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!